GlaxoSmithKline LLC et al v. Natco Pharma Ltd. et al
| Delaware District Court | |
| Judge: | Colm F Connolly |
| Case #: | 1:26-cv-00168 |
| Nature of Suit | 835 Property Rights - Patent – Abbreviated New Drug Application |
| Cause | 35:1 Patent Infringement |
| Case Filed: | Feb 13, 2026 |
| Last checked: Monday Mar 30, 2026 3:47 AM EDT |
|
Defendant
Natco Pharma Ltd.
|
Represented By
|
|
Defendant
Natco Pharma USA LLC
|
Represented By
|
|
Plaintiff
GlaxoSmithKline LLC
|
Represented By
|
|
Plaintiff
Merck Sharp & Dohme LLC
|
Represented By
|
|
Plaintiff
TESARO, Inc.
|
Represented By
|
| Docket last updated: 06/12/2026 11:59 PM EDT |
| Monday, April 06, 2026 | ||
| 22 | 22
notice
Notice re Attorney Appearance - Requesting Removal of Co-Counsel
Mon 04/06 3:06 PM
NOTICE requesting Clerk to remove Scott G. Greene as co-counsel.. (Silver, Daniel) |
|
| Thursday, April 02, 2026 | ||
| 21 | 21
order
SO ORDERED
Thu 04/02 7:58 AM
SO ORDERED, re (47 in 1:25-cv-01170-CFC, 19 in 1:26-cv-00168-CFC) STIPULATION Regarding Case Consolidation and Amended Case Schedule filed by GlaxoSmithKline LLC, Merck Sharp & Dohme LLC, TESARO, Inc. Signed by Judge Colm F. Connolly on 4/1/2026. Associated Cases: 1:25-cv-01170-CFC, 1:26-cv-00168-CFC (mws) |
|
|
utility
Create Case Association - dkt in member case for Consol or MDL
Thu 04/02 8:00 AM
Case associated with lead case: Create association to 1:25-cv-01170-CFC. ALL FUTURE FILINGS SHALL BE MADE IN LEAD CASE NO. 25-1170 CFC ONLY. (mws) |
||
|
utility
Remark
Thu 04/02 8:04 AM
Remark: The April 7, 2026 Rule 16 Scheduling Conference is cancelled. (mws) |
||
| Wednesday, April 01, 2026 | ||
| 20 | 20
misc
Letter
Wed 04/01 4:32 PM
Letter to Chief Judge Connolly from Alexandra M. Joyce regarding Joint Request to Remove April 7, 2026 Rule 16 Conference from the Courts Calendar. (Joyce, Alexandra) |
|
| Tuesday, March 31, 2026 | ||
| 19 | 19
motion
Stipulation-General
Tue 03/31 6:21 PM
STIPULATION and Order Regarding Case Consolidation and Amended Case Schedule - filed by GlaxoSmithKline LLC, Merck Sharp & Dohme LLC, TESARO, Inc.. (Joyce, Alexandra) |
|
|
utility
Add Attorneys - PHV only
Tue 03/31 1:13 PM
Pro Hac Vice Attorney River E. Lord, Joanna Garelick Goldstein,Christopher J. Sorenson, Jason M. Wiener for Natco Pharma Ltd., Natco Pharma USA LLC added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (lah) |
||
| Thursday, March 26, 2026 | ||
| 18 | 18
misc
-District Court Pro Hac Vice Fee - 05 Attorneys Credit Card Payment
Thu 03/26 11:42 AM
Pro Hac Vice Fee - Credit Card Payment received for Christopher J. Sorenson, River Lord, Jason M. Wiener, Joanna Garelick Goldstein, and Andrew O. Larsen, Ph.D.. ( re17 MOTION for Pro Hac Vice Appearance of Attorney Christopher J. Sorenson, River Lord, Jason M. Wiener, Joanna Garelick Goldstein and Andrew O. Larsen, Ph.D. )( Payment of $ 250, receipt number ADEDC-4932661).(Pedi, Nicole) |
|
| 17 | 17
motion
Appear Pro Hac Vice
Thu 03/26 11:31 AM
MOTION for Pro Hac Vice Appearance of Attorney Christopher J. Sorenson, River Lord, Jason M. Wiener, Joanna Garelick Goldstein and Andrew O. Larsen, Ph.D. - filed by Natco Pharma Ltd., Natco Pharma USA LLC. (Pedi, Nicole) |
|
|
utility
Add Attorneys - PHV only
Thu 03/26 7:55 AM
Pro Hac Vice Attorney Timothy A. Cook, Christopher M. Cherry, Christopher R. Noyes, Anna Wong & Reshma C. Gogineni for GlaxoSmithKline LLC, Merck Sharp & Dohme LLC & TESARO, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (slk) |
||
|
order
SO ORDERED
Thu 03/26 11:46 AM
SO ORDERED, re17 MOTION for Pro Hac Vice Appearance of Attorney Christopher J. Sorenson, River Lord, Jason M. Wiener, Joanna Garelick Goldstein and Andrew O. Larsen, Ph.D., filed by Natco Pharma Ltd., Natco Pharma USA LLC. Ordered by Judge Colm F. Connolly on 3/26/2026. (kmd) |
||
| Monday, March 23, 2026 | ||
| 16 | 16
misc
-District Court Pro Hac Vice Fee - 01 Attorney Credit Card Payment
Mon 03/23 12:44 PM
Pro Hac Vice Fee - Credit Card Payment received for Anna Wong. ( re14 MOTION for Pro Hac Vice Appearance of Attorney Christopher R. Noyes, Timothy A. Cook, Scott G. Greene, Reshma C. Gogineni, Christopher M. Cherry, and Anna Wong )( Payment of $ 50, receipt number ADEDC-4929464).(Silver, Daniel) |
|
| 15 | 15
misc
-District Court Pro Hac Vice Fee - 05 Attorneys Credit Card Payment
Mon 03/23 12:43 PM
Pro Hac Vice Fee - Credit Card Payment received for Christopher R. Noyes, Timothy A. Cook, Scott G. Greene, Reshma C. Gogineni, and Christopher M. Cherry. ( re14 MOTION for Pro Hac Vice Appearance of Attorney Christopher R. Noyes, Timothy A. Cook, Scott G. Greene, Reshma C. Gogineni, Christopher M. Cherry, and Anna Wong )( Payment of $ 250, receipt number ADEDC-4929456).(Silver, Daniel) |
|
| 14 | 14
motion
Appear Pro Hac Vice
Mon 03/23 12:38 PM
MOTION for Pro Hac Vice Appearance of Attorney Christopher R. Noyes, Timothy A. Cook, Scott G. Greene, Reshma C. Gogineni, Christopher M. Cherry, and Anna Wong - filed by GlaxoSmithKline LLC, Merck Sharp & Dohme LLC, TESARO, Inc..(Silver, Daniel) |
|
|
Att: 1
Certifications for Christopher R. Noyes, Timothy A. Cook, Scott G. Greene, Reshma C. Gogineni, Christopher M. Cherry, and Anna Wong
|
||
|
order
SO ORDERED
Mon 03/23 12:47 PM
SO ORDERED, re14 MOTION for Pro Hac Vice Appearance of Attorney Christopher R. Noyes, Timothy A. Cook, Scott G. Greene, Reshma C. Gogineni, Christopher M. Cherry, and Anna Wong, filed by GlaxoSmithKline LLC, Merck Sharp & Dohme LLC, TESARO, Inc. Ordered by Judge Colm F. Connolly on 3/23/2026. (kmd) |
||
| Monday, March 09, 2026 | ||
| 13 | 13
1
pgs
order
Order Setting Scheduling Conference
Mon 03/09 2:35 PM
Order Setting Telephonic Scheduling Conference: A Telephonic Scheduling Conference is set for 4/7/2026 at 09:00 AM before Judge Colm F. Connolly. If the parties have no disputes about the scheduling order, the Court will not require the parties to appear at a conference. Signed by Judge Colm F. Connolly on 3/9/2026. (mws) |
|
| Friday, March 06, 2026 | ||
| 12 | 12
misc
Disclosure Statement - Rule 7.1
Fri 03/06 5:05 PM
Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent No Corporate Parent for Natco Pharma Ltd.; Corporate Parent Natco Pharma Ltd. for Natco Pharma USA LLC filed by Natco Pharma Ltd., Natco Pharma USA LLC. (Pedi, Nicole) |
|
| 11 | 11
answer
Answer to Complaint
Fri 03/06 4:54 PM
ANSWER to1 Complaint, and Affirmative Defenses by Natco Pharma Ltd., Natco Pharma USA LLC.(Cragg, Tyler) |
|
| Monday, February 23, 2026 | ||
| 10 | 10
misc
Declaration
Mon 02/23 2:03 PM
DECLARATION of Service for Natco Pharma Ltd. by GlaxoSmithKline LLC, Merck Sharp & Dohme LLC, TESARO, Inc.. (Joyce, Alexandra) |
|
| Wednesday, February 18, 2026 | ||
| 9 | 9
service
Summons Returned Executed
Wed 02/18 11:52 AM
SUMMONS Returned Executed by GlaxoSmithKline LLC, Merck Sharp & Dohme LLC, TESARO, Inc..Natco Pharma USA LLC served on 2/17/2026, answer due 3/10/2026. (Silver, Daniel) |
|
| 8 | 8
2
pgs
order
Order
Wed 02/18 10:27 AM
STANDING ORDER REGARDING BRIEFING IN ALL CASES (mws) |
|
|
utility
Case Assigned/Reassigned
Wed 02/18 7:20 AM
Case Assigned to Judge Colm F. Connolly. Please include the initials of the Judge (CFC) after the case number on all documents filed. (alb) |
||
| Tuesday, February 17, 2026 | ||
| 7 | 7
service
Summons Issued
Tue 02/17 11:15 AM
Summons Issued as to Natco Pharma Ltd. on 2/17/2026; Natco Pharma USA LLC on 2/17/2026.(mrr) |
|
|
Att: 1
Summons Issued
|
||
|
utility
- CORRECTING ENTRY
Tue 02/17 1:52 PM
CORRECTING ENTRY: The stay deadline at D.I.3 has been corrected. (nms) |
||
| Friday, February 13, 2026 | ||
| 6 | 6
misc
Patent/Trademark Report to Commissioner of Patents
Tue 02/17 11:14 AM
Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 11,091,459; 11,673,877. (mrr) |
|
| 5 | 5
misc
Disclosure Statement - Rule 7.1
Tue 02/17 11:12 AM
Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Merck & Co., Inc. for Merck Sharp & Dohme LLC filed by Merck Sharp & Dohme LLC. (mrr) |
|
| 4 | 4
misc
Disclosure Statement - Rule 7.1
Tue 02/17 11:09 AM
Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent GSK plc for GlaxoSmithKline LLC; Corporate Parent GlaxoSmithKline LLC, Other Affiliate GSK plc for TESARO, Inc. filed by GlaxoSmithKline LLC, TESARO, Inc. (mrr) |
|
| 3 | 3
misc
ANDA Form
Tue 02/17 11:03 AM
Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 1/9/2026. Date of Expiration of Patent: 11,091,459, Expiration date: 3/27/2038 & 11,673,877 Date of Expiration: 3/27/2038. Thirty Month Stay Deadline: No earlier than 7/9/2028. (mrr) Modified on 2/17/2026 (nms) |
|
| 2 | 2
misc
Magistrate Consent Forms
Tue 02/17 10:55 AM
Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (mrr) |
|
| 1 | 1
13
pgs
cmp
Complaint
Tue 02/17 10:53 AM
COMPLAINT for Patent Infringement against Natco Pharma Ltd., Natco Pharma USA LLC (Filing fee $ 405, receipt number ADEDC-4900762) - filed by GlaxoSmithKline LLC, Merck Sharp & Dohme LLC, TESARO, Inc.(mrr) |
|
|
Att: 1
Exhibits A-B,
|
||
|
Att: 2
Civil Cover Sheet
|
||